The ADAP WatchApril 22, 2011
As of April 22, 2011, there were 7,674 individuals on AIDS Drug Assistance Program (ADAP) waiting lists in 11 states.
This is a 23 percent increase from the 6,235 individuals on the February 2011 ADAP Watch. Eighteen ADAPs, 10 with current waiting lists, have instituted additional cost-containment measures since April 1, 2009 (reported as of April 13, 2011). In addition, 14 ADAPs, including four with current waiting lists, reported they are considering implementing new or additional cost-containment measures by the end of ADAP's current fiscal year (March 31, 2012). States that have instituted cost containment measures and those considering them, in addition to implementing waiting lists, are reducing program financial and medical eligibility, capping enrollment, reducing the number of drugs on the formulary and cutting other services, all of which impact access to life saving HIV medications for medically vulnerable individuals. ADAPs With Current or Anticipated Cost-Containment Measures, Including Waiting Lists, April 2011ADAPs With Waiting Lists (7,674 Individuals in 11 States*, as of April 21, 2011)Arkansas: 63 individuals ADAPs With Other Cost-Containment Strategies (Instituted Since April 1, 2009, as of April 13, 2011)Arizona: reduced formulary ADAPs Considering New/Additional Cost-Containment Measures (Before March 31, 2012***)Alabama: cap enrollment, establish waiting list (as of May 1, 2011), reduce formulary * As a result of ADAP emergency funding, Hawaii, Idaho, Iowa, Kentucky, South Dakota and Utah eliminated their waiting lists; Idaho reinstituted a waiting list in February 2011. This article was provided by National Alliance of State and Territorial AIDS Directors. Visit NASTAD's website to find out more about their activities and publications.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|